• Interesting ... Clinical Trial for Monthly Nivolumab vs Biweekly

    Asked by LiveWithCancer on Tuesday, May 15, 2018

    Interesting ... Clinical Trial for Monthly Nivolumab vs Biweekly

    I was trying to write a blog about the availability of treatments at the NIH ... which led me to a site called ResearchMatch.org. I completed a brief questionnaire and the program showed me a lot of clinical trials for which I might be eligible.

    I guess I have more time than sense because I started going through it ... and lo and behold, there's a clinical trial underway studying progression-free survival rates at 6 months and 1 year of Nivolumab every 4 weeks compared to Nivolumab every 2 weeks.

    Hmmm, I thought maybe I could save my insurance companies some money and get back into a clinical trial :) But, I would have to change hospitals to do so.

    Anyway, anyone else think this is an "interesting" study given the fact that FDA has already approved Nivolumab every 4 weeks???? Is this putting the cart before the horse?

    2 Answers from the Community

    • SandiA's Avatar
      SandiA

      That’s interesting. I would think that would be done first!

      5 months ago
    • LiveWithCancer's Avatar
      LiveWithCancer

      @SandiA, me too!!!!!!!!!!!!!!!! I wasn't altogether happy to see the trial availability!! I did look to see if my hospital offered it - I was going to see if I could get into it (probably would have been too late since I already had two monthly infusions).

      5 months ago

    Help the community by answering this question:

    Create an account to post your answer Already have an account? Sign in!

    By using WhatNext, you agree to our User Agreement, and Privacy Policy


    Read and answer more adenocarcinoma, lung cancer questions.  Also, don't forget to check out our Adenocarcinoma, Lung Cancer page.